New study aims to unlock secrets of tough Crohn's cases

NCT ID NCT07364734

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 1,400 adults with Crohn's disease across multiple hospitals in China to understand how common hard-to-treat cases are and how well current treatments work. Researchers will compare patients who respond poorly to therapy with those who do better, and look for factors that predict worsening disease within a year. The goal is to improve treatment choices for people with difficult Crohn's.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better identify which Crohn's patients need stronger treatments earlier, improving long-term outcomes.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sixth Affiliated Hospital, Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510655, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••